SPONSOR
Regina Elena Cancer Institute
Total Trials
5
Recruiting
5
Phases
N/A
Conditions studied: Osteoporosis SecondaryBreast Cancer FemalesThyroid NoduleBladder CancerBreast Cancer
Regina Elena Cancer Institute is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Osteoporosis Secondary, Breast Cancer Females, Thyroid Nodule, Bladder Cancer.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Regina Elena Cancer Institute
How many clinical trials has Regina Elena Cancer Institute sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Regina Elena Cancer Institute, of which 5 are actively recruiting participants. These trials cover conditions including Osteoporosis Secondary, Breast Cancer Females, Thyroid Nodule. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Regina Elena Cancer Institute research focus on?
Regina Elena Cancer Institute clinical trials span Osteoporosis Secondary, Breast Cancer Females, Thyroid Nodule, Bladder Cancer, Breast Cancer. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Regina Elena Cancer Institute clinical trial?
To participate in a Regina Elena Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Regina Elena Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Regina Elena Cancer Institute
NCT07256769
Recruiting
Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis
Osteoporosis Secondary
NCT06736015
Recruiting
Myo-inositol and Selenium in Indeterminate Thyroid Nodules (TIR3a)
Thyroid Nodule
NCT06992986
Recruiting
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
Bladder Cancer
NCT06272799
Recruiting
Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.
Breast Cancer
NCT06883201
Recruiting
Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology